Under the agreement, Philips and Flevo Hospital will also work on innovation programs aimed at introducing innovative technologies and ensuring their optimal use, such as expanding patient monitoring in the hospital, as well as facilitating care outside the hospital. Another goal focuses on further enhancing the staff experience to foster passionate and committed employees. Each year, an education plan will be agreed on for the development and education of healthcare providers and medical technicians in the hospital, so that Philips' technology can be used optimally and efficiently for patient care.


About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

Back to HCB News

CT Homepage